190 related articles for article (PubMed ID: 32849842)
1. Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance.
Xiong Y; Yang G; Wang K; Riaz M; Xu J; Lv Z; Zhou H; Li Q; Li W; Sun J; Tao T; Li J
Front Genet; 2020; 11():879. PubMed ID: 32849842
[TBL] [Abstract][Full Text] [Related]
2. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
3. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Zhao J; Chang L; Gu X; Liu J; Sun B; Wei X
Cancer Sci; 2020 Aug; 111(8):3020-3031. PubMed ID: 32530556
[TBL] [Abstract][Full Text] [Related]
4. Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance.
Lin C; Yu B; Zhang M; Chen Y; Li L; Zhao D
Front Genet; 2020; 11():522831. PubMed ID: 33281863
[TBL] [Abstract][Full Text] [Related]
5. Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data.
Du JX; Liu YL; Zhu GQ; Luo YH; Chen C; Cai CZ; Zhang SJ; Wang B; Cai JL; Zhou J; Fan J; Dai Z; Zhu W
Ann Transl Med; 2021 Jan; 9(1):58. PubMed ID: 33553351
[TBL] [Abstract][Full Text] [Related]
6. Profiles of alternative splicing events in the diagnosis and prognosis of Gastric Cancer.
Wei C; Xie W; Huang X; Mo X; Liu Z; Wu G; Meng Y; Jeen F; Ge L; Zhang L; Liao L; Liu J; Tang W
J Cancer; 2021; 12(10):2982-2992. PubMed ID: 33854599
[No Abstract] [Full Text] [Related]
7. Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis.
Luo D; Zhao D; Zhang M; Hu C; Li H; Zhang S; Chen X; Huttad L; Li B; Jin C; Lin C; Han B
Front Oncol; 2021; 11():731993. PubMed ID: 34760694
[TBL] [Abstract][Full Text] [Related]
8. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
[TBL] [Abstract][Full Text] [Related]
9. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
Yang L; He Y; Zhang Z; Wang W
PeerJ; 2019; 7():e8245. PubMed ID: 31844595
[TBL] [Abstract][Full Text] [Related]
10. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
11. Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis.
Yao J; Tang YC; Yi B; Yang J; Chai Y; Yin N; Zhang ZX; Wei YJ; Li DC; Zhou J
J Cancer; 2021; 12(11):3164-3179. PubMed ID: 33976726
[TBL] [Abstract][Full Text] [Related]
12. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL
Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164
[TBL] [Abstract][Full Text] [Related]
13. Role of alternative splicing events in endometrial cancer prognosis.
Liu J; Mi C; Long W; Sun T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):680-688. PubMed ID: 34382583
[TBL] [Abstract][Full Text] [Related]
14. Systematic profiling of alternative splicing in
Liu C; Hu C; Li Z; Feng J; Huang J; Yang B; Wen T
Cancer Cell Int; 2020; 20():279. PubMed ID: 32617077
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer.
Li S; Hu Z; Zhao Y; Huang S; He X
Hepatology; 2019 Jan; 69(1):359-375. PubMed ID: 30014619
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
17. Prognostic alternative mRNA splicing signature in hepatocellular carcinoma: a study based on large-scale sequencing data.
Zhu GQ; Zhou YJ; Qiu LX; Wang B; Yang Y; Liao WT; Luo YH; Shi YH; Zhou J; Fan J; Dai Z
Carcinogenesis; 2019 Sep; 40(9):1077-1085. PubMed ID: 31099827
[TBL] [Abstract][Full Text] [Related]
18. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
19. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors.
Jin YJ; Byun S; Han S; Chamberlin J; Kim D; Kim MJ; Lee Y
BMC Med Genomics; 2019 Dec; 12(Suppl 8):175. PubMed ID: 31856847
[TBL] [Abstract][Full Text] [Related]
20. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
Xing L; Zhang X; Tong D
DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]